StockData
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. (CTKB) stock

CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.92+0.22 (+3.86%)

Close on Nov 18, 2026Market cap $769.50MP/E –Yield –

Cytek Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cytek Biosciences's market cap was $748.70M on Nov 11, 2026, against $722.44M a year earlier. Over the last 5 years it ranged from $353.45M to $2.18B, with a median of $796.79M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$748.70M+15.9%
2025Dec 31, 2025$645.72M-23.3%
2024Dec 31, 2024$842.18M-31.9%
2023Dec 29, 2023$1.24B-10.2%
2022Dec 30, 2022$1.38B-36.9%
2021Dec 31, 2021$2.18B–

More Cytek Biosciences figures

See a number that looks wrong?